Placental Nkx2-5 and target gene expression in early-onset and severe preeclampsia

References

• Duley L. The global impact of preeclampsia and eclampsia. Semin Perinatol 2009;33:130–7
   PubMed Web of Science ®Google Scholar
• Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Preeclampsia. Lancet 2010;376:631–44
   PubMed Web of Science ®Google Scholar
• Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 2001;357:2002–6
   PubMed Web of Science ®Google Scholar
• Skjaerven R, Wilcox AJ, Klungsoyr K, et al. Cardiovascular mortality after preeclampsia in one child mothers: prospective, population based cohort study. BMJ 2012;345:e7677
   PubMedGoogle Scholar
• Jonsdottir LS, Arngrimsson R, Geirsson RT, et al. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand 1995;74:772–6
   PubMed Web of Science ®Google Scholar
• Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after preeclampsia: population based cohort study. BMJ 2001;323:1213–17
   PubMed Web of Science ®Google Scholar
• Funai EF, Friedlander Y, Paltiel O, et al. Long-term mortality after preeclampsia. Epidemiology 2005;16:206–15
   PubMed Web of Science ®Google Scholar
• Wikstrom AK, Haglund B, Olovsson M, Lindeberg SN. The risk of maternal ischaemic heart disease after gestational hypertensive disease. BJOG 2005;112:1486–91
   PubMed Web of Science ®Google Scholar
• Lykke JA, Paidas MJ, Damm P, et al. Preterm delivery and risk of subsequent cardiovascular morbidity and type-ii diabetes in the mother. BJOG 2010;117:274–81
   PubMedGoogle Scholar
• Lykke JA, Langhoff-Roos J, Sibai BM, et al. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension 2009;53:944–51
   PubMed Web of Science ®Google Scholar
• Davis EF, Lazdam M, Lewandowski AJ, et al. Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review. Pediatrics 2012;129:e1552–61
   PubMed Web of Science ®Google Scholar
• Carr DB, Newton KM, Utzschneider KM, et al. Gestational diabetes or lesser degrees of glucose intolerance and risk of preeclampsia. Hypertens Pregnancy 2011;30:153–63
   PubMed Web of Science ®Google Scholar
• Vikse BE, Irgens LM, Karumanchi SA, et al. Familial factors in the association between preeclampsia and later ESRD. Clin J Am Soc Nephrol 2012;7:1819–26
   PubMed Web of Science ®Google Scholar
• Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension 2005;46:1243–9
   PubMed Web of Science ®Google Scholar
• Thadhani R, Mutter WP, Wolf M, et al. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 2004;89:770–5
   PubMed Web of Science ®Google Scholar
• Reuvekamp A, Velsing-Aarts FV, Poulina IE, et al. Selective deficit of angiogenic growth factors characterises pregnancies complicated by preeclampsia. Br J Obstet Gynaecol 1999;106:1019–22
   PubMedGoogle Scholar
• Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006;12:642–9
   PubMed Web of Science ®Google Scholar
• Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sflt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649–58
   PubMed Web of Science ®Google Scholar
• Rana S, Karumanchi SA, Lindheimer MD. Angiogenic factors in diagnosis, management, and research in preeclampsia. Hypertension 2014;63:198–202
   PubMed Web of Science ®Google Scholar
• Robinson CJ, Johnson DD, Chang EY, et al. Evaluation of placenta growth factor and soluble fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia. Am J Obstet Gynecol 2006;195:255–9
   PubMed Web of Science ®Google Scholar
• Moore Simas TA, Crawford SL, Solitro MJ, et al. Angiogenic factors for the prediction of preeclampsia in high-risk women. Am J Obstet Gynecol 2007;197:244 e241–8
   Web of Science ®Google Scholar
• Stepan H, Unversucht A, Wessel N, Faber R. Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion. Hypertension 2007;49:818–24
   PubMed Web of Science ®Google Scholar
• Karumanchi SA, Lindheimer MD. Advances in the understanding of eclampsia. Curr Hypertens Rep 2008;10:305–12
   PubMedGoogle Scholar
• He Y, Smith SK, Day KA, et al. Alternative splicing of vascular endothelial growth factor VEGF-R1 (flt-1) pre-mRNA is important for the regulation of VEGF activity. Mol Endocrinol 1999;13:537–45
   PubMed Web of Science ®Google Scholar
• Rana S, Hacker MR, Modest AM, et al. Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia. Hypertension 2012;60:451–8
   PubMed Web of Science ®Google Scholar
• Carr DB, Tran LT, Brateng DA, et al. Hemodynamically-directed atenolol therapy is associated with a blunted rise in maternal sflt-1 levels during pregnancy. Hypertens Pregnancy 2009;28:42–55
   PubMed Web of Science ®Google Scholar
• Lu F, Longo M, Tamayo E, et al. The effect of over-expression of sflt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. Am J Obstet Gynecol 2007;196:396 e391–7; discussion 396 e397
   Google Scholar
• Costantine MM, Tamayo E, Lu F, et al. Using pravastatin to improve the vascular reactivity in a mouse model of soluble fms-like tyrosine kinase-1-induced preeclampsia. Obstet Gynecol 2010;116:114–20
   PubMed Web of Science ®Google Scholar
• Mateus J, Bytautiene E, Lu F, et al. Endothelial growth factor therapy improves preeclampsia-like manifestations in a murine model induced by overexpression of sVEGF-1. Am J Physiol Heart Circul Physiol 2011;301:H1781–7
   PubMedGoogle Scholar
• Verlohren S, Herraiz I, Lapaire O, et al. New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia. Hypertension 2014;63:346–52
   PubMed Web of Science ®Google Scholar
• Engels T, Pape J, Schoofs K, et al. Automated measurement of sflt1, PlGF and sflt1/PlGF ratio in differential diagnosis of hypertensive pregnancy disorders. Hypertens Pregnancy 2013;32:459–73
   PubMed Web of Science ®Google Scholar
• Schott JJ, Benson DW, Basson CT, et al. Congenital heart disease caused by mutations in the transcription factor Nkx2-5. Science 1998;281:108–11
   PubMed Web of Science ®Google Scholar
• Benson DW. Genetic origins of pediatric heart disease. Pediatr Cardiol 2010;31:422–9
   PubMed Web of Science ®Google Scholar
• Lints TJ, Parsons LM, Hartley L, et al. Nkx-2.5: a novel murine homeobox gene expressed in early heart progenitor cells and their myogenic descendants. Development (Cambridge, England) 1993;119:419–31
   PubMed Web of Science ®Google Scholar
• McElhinney DB, Geiger E, Blinder J, et al. Nkx2.5 mutations in patients with congenital heart disease. J Am Coll Cardiol 2003;42:1650–5
   PubMed Web of Science ®Google Scholar
• Tanaka M, Chen Z, Bartunkova S, et al. The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development. Development 1999;126:1269–80
   PubMed Web of Science ®Google Scholar
• Stanley EG, Biben C, Elefanty A, et al. Efficient Cre-mediated deletion in cardiac progenitor cells conferred by a 3′UTR-ires-Cre allele of the homeobox gene Nkx2-5. Int J Dev Biol 2002;46:431–9
   PubMedGoogle Scholar
• Robinson CJ, Wagner CL, Hollis BW, et al. Maternal vitamin D and fetal growth in early-onset severe preeclampsia. Am J Obstet Gynecol 2011;204:556 e551–4
   Google Scholar
• ACOG Practice Bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 2002;99:159–67
   PubMed Web of Science ®Google Scholar
• Bajpai R, Terskikh A. Genetic manipulation of human embryonic stem cells: lentivirus vectors. In: Loring JF, Wesselschmidt RL, Schwartz PH, eds. Human stem cell manual: a laboratory guide. Academic Press; 2007:255–66
   Google Scholar
• NIH. ImageJ: http://rsb.info.nih.gov/ij/
   Google Scholar
• Zhao S, Fernald RD. Comprehensive algorithm for quantitative real-time polymerase chain reaction. J Comput Biol 2005;12:1047–64
   PubMed Web of Science ®Google Scholar
• Carlson CD, Warren CL, Hauschild KE, et al. Specificity landscapes of DNA binding molecules elucidate biological function. Proc Natl Acad Sci USA 2010;107:4544–9
   PubMedGoogle Scholar
• Barth JL, Clark CD, Fresco VM, et al. Jarid2 is among a set of genes differentially regulated by Nkx2.5 during outflow tract morphogenesis. Dev Dyn 2010;239:2024–33
   PubMedGoogle Scholar
• Matter N, Herrlich P, Konig H. Signal-dependent regulation of splicing via phosphorylation of sam68. Nature 2002;420:691–5
   PubMed Web of Science ®Google Scholar
• McLaren M, Asai K, Cochrane A. A novel function for sam68: enhancement of HIV-1 RNA 3′ end processing. RNA 2004;10:1119–29
   PubMedGoogle Scholar
• Thomas CP, Andrews JI, Liu KZ. Intronic polyadenylation signal sequences and alternate splicing generate human soluble flt1 variants and regulate the abundance of soluble flt1 in the placenta. FASEB J: Off Publ Feder Am Soc Exp Biol 2007;21:3885–95
   PubMedGoogle Scholar
• Huckle WR, Roche RI. Post-transcriptional control of expression of sflt-1, an endogenous inhibitor of vascular endothelial growth factor. J Cell Biochem 2004;93:120–32
   PubMedGoogle Scholar
• Kent WJ, Sugnet CW, Furey TS, et al. The human genome browser at UCSC. Genome Res 2002;12:996–1006
   PubMed Web of Science ®Google Scholar
• Lian IA, Loset M, Mundal SB, et al. Increased endoplasmic reticulum stress in decidual tissue from pregnancies complicated by fetal growth restriction with and without preeclampsia. Placenta 2011;32:823–9
   PubMed Web of Science ®Google Scholar
• Ahmad S, Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res 2004;95:884–91
   PubMed Web of Science ®Google Scholar
• Catalano PM. Management of obesity in pregnancy. Obstet Gynecol 2007;109:419–33
   PubMed Web of Science ®Google Scholar
• Germain S, Nelson-Piercy C. Lupus nephritis and renal disease in pregnancy. Lupus 2006;15:148–55
   PubMed Web of Science ®Google Scholar
• Powe CE, Thadhani R. Diabetes and the kidney in pregnancy. Semin Nephrol 2011;31:59–69
   PubMed Web of Science ®Google Scholar
• Roberts JM, Pearson GD, Cutler JA, Lindheimer MD. Summary of the nhlbi working group on research on hypertension during pregnancy. Hypertens Pregnancy 2003;22:109–27
   PubMed Web of Science ®Google Scholar
• Bigelow CA, Pereira GA, Warmsley A, et al. Risk factors for new-onset late postpartum preeclampsia in women without a history of preeclampsia. Am J Obstet Gynecol 2014;210:338e1–8
   Google Scholar
• Shahabi A, Wilson ML, Lewinger JP, et al. Genetic admixture and risk of hypertensive disorders of pregnancy among Latinas in Los Angeles County. Epidemiology 2013;24:285–94
   PubMedGoogle Scholar
• Knuist M, Bonsel GJ, Zondervan HA, Treffers PE. Risk factors for preeclampsia in nulliparous women in distinct ethnic groups: a prospective cohort study. Obstet Gynecol 1998;92:174–8
   PubMed Web of Science ®Google Scholar
• Jebbink J, Wolters A, Fernando F, et al. Molecular genetics of preeclampsia and HELLP syndrome – a review. Biochim Biophys Acta 2012;1822:1960–9
   PubMed Web of Science ®Google Scholar